Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 of Carbetocin for Postpartum Uterine Atony Prevention
NCT01579201Phase 4Unknown
- Sponsor
- Hôpital Maisonneuve-Rosemont
- Start
- Mar 2012
- Primary completion
- Mar 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of carbetocin in postpartum hemorrhage (PPH), uterine atony, sponsored by Hôpital Maisonneuve-Rosemont. Status: unknown.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)uterine atony
Beyond the preview
Go deeper on NCT01579201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01579201.